Application of Ultrasound-guided Placement of Markers for Locating Axillary Lymph Nodes of Breast Cancer

Overview

Journal Gland Surg

Publisher AME Publishing Company

Specialty Endocrinology

Date 2021 Dec 20

PMID 34926222

Citations 1

Authors

Xiaohui Ji

Mengying Wei

Liuyuan Wang

Juanjuan Li

Dongxia Gao

Cuizhi Geng

Affiliations

Soon will be listed here.

Abstract

Background: With the continuous improvement of pathological complete response (pCR) rate after neoadjuvant therapy (NAT), it is necessary to locate the tumor bed and axillary lymph nodes (ALNs) for subsequent surgery. Therefore, breast tissue markers emerge. This study aims to evaluate the feasibility and accuracy of ultrasound (US)-guided placement of markers for locating ALNs of breast cancer.

Methods: A total of 285 patients who received US-guided placement of markers for locating ALNs in our hospital were selected. Among these patients, 87 patients were in the early breast cancer (EBC) group with negative ALNs and 198 ones were in the NAT group with positive ALNs. Data including the basic information of patients, position and size of ALN, process of US-guided marker placement, placement success rate, complications, detection rate of marker by imaging, and shift rate were recorded.

Results: All patients were successfully undergone US-guided marker placement. And the average operation time was 2 minutes with no adverse reactions. All the patients underwent surgery successfully. US, computer tomography (CT) and magnetic resonance imaging (MRI) were used to detect the marker. The detection rate of markers by US and CT/MRI were 100% (87/87) in EBC group, and 98.5% (195/198) and 100% (198/198) by US and CT/MRI, respectively, in NAT group. The postoperative marker shift rate was 2.1% (6/285), including 3.4% (3/87) marker shift rate in EBC group and 1.5% (3/198) in NAT group, with no statistically significant difference between them.

Conclusions: US-guided marker placement in ALNs of breast cancer is simple and safe, with firm positioning and low shift rate, which is convenient for clinical promotion.

Citing Articles

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.

Reijers I, Menzies A, van Akkooi A, Versluis J, van den Heuvel N, Saw R Nat Med. 2022; 28(6):1178-1188.

PMID: 35661157 DOI: 10.1038/s41591-022-01851-x.

References

Genson C, Blane C, Helvie M, Waits S, Chenevert T . Effects on breast MRI of artifacts caused by metallic tissue marker clips. AJR Am J Roentgenol. 2007; 188(2):372-6. DOI: 10.2214/AJR.05.1254. View

Motton S, Gardinal I, Soule-Tholy M, Viraben R, Hoff J, Leguevaque P . [Hurt eczematiforme column (chronicle) of the breast after implementation of a surgical clip]. J Gynecol Obstet Biol Reprod (Paris). 2010; 40(2):174-7. DOI: 10.1016/j.jgyn.2010.07.010. View

Dash N, Chafin S, Johnson R, Contractor F . Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am J Roentgenol. 1999; 173(4):911-7. DOI: 10.2214/ajr.173.4.10511147. View

Krag D, Anderson S, Julian T, Brown A, Harlow S, Ashikaga T . Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007; 8(10):881-8. DOI: 10.1016/S1470-2045(07)70278-4. View

. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2017; 19(1):27-39. PMC: 5757427. DOI: 10.1016/S1470-2045(17)30777-5. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Hartmann S, Reimer T, Gerber B, Stubert J, Stengel B, Stachs A . Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol. 2018; 44(9):1307-1311. DOI: 10.1016/j.ejso.2018.05.035. View

Pinkney D, Mychajlowycz M, Shah B . A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers. Br J Radiol. 2016; 89(1065):20160149. PMC: 5124921. DOI: 10.1259/bjr.20160149. View

Kim E, Byon W, Lee K, Yun J, Park Y, Park C . Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study. World J Surg. 2017; 42(2):582-589. DOI: 10.1007/s00268-017-4171-8. View

10.

McMasters K, Giuliano A, Ross M, Reintgen D, Hunt K, Byrd D . Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med. 1998; 339(14):990-5. DOI: 10.1056/NEJM199810013391410. View

11.

van Deurzen C, Vriens B, Tjan-Heijnen V, van der Wall E, Albregts M, van Hilligersberg R . Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer. 2009; 45(18):3124-30. DOI: 10.1016/j.ejca.2009.08.001. View

12.

Whaley D, Adamczyk D, Jensen E . Sonographically guided needle localization after stereotactic breast biopsy. AJR Am J Roentgenol. 2003; 180(2):352-4. DOI: 10.2214/ajr.180.2.1800352. View

13.

Schulz-Wendtland R, Dankerl P, Bani M, Fasching P, Heusinger K, Lux M . Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy. Geburtshilfe Frauenheilkd. 2017; 77(2):169-175. PMC: 5357217. DOI: 10.1055/s-0042-124191. View

14.

Boughey J, Suman V, Mittendorf E, Ahrendt G, Wilke L, Taback B . Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013; 310(14):1455-61. PMC: 4075763. DOI: 10.1001/jama.2013.278932. View

15.

Tamai K, Mitsumori M, Fujishiro S, Kokubo M, Ooya N, Nagata Y . A case of allergic reaction to surgical metal clips inserted for postoperative boost irradiation in a patient undergoing breast-conserving therapy. Breast Cancer. 2001; 8(1):90-2. DOI: 10.1007/BF02967485. View

16.

Zografos G, Zagouri F, Sergentanis T, Panou M, Dardamanis D, Giannakopoulou G . Psychiatric disorder associated with vacuum-assisted breast biopsy clip placement: a case report. J Med Case Rep. 2008; 2:332. PMC: 2579921. DOI: 10.1186/1752-1947-2-332. View

17.

Perlet C, Sittek H, Reiser M, Heywang-Kobrunner S . [Clip marker placement following MR-guided vacuum biopsy of the breast]. Radiologe. 2005; 45(3):230-6. DOI: 10.1007/s00117-005-1173-6. View

18.

Boughey J, Suman V, Mittendorf E, Ahrendt G, Wilke L, Taback B . Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg. 2015; 261(3):547-52. PMC: 4324533. DOI: 10.1097/SLA.0000000000000551. View

19.

Rosen E, Vo T . Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology. 2001; 218(2):510-6. DOI: 10.1148/radiology.218.2.r01fe39510. View

20.

Zavagno G, De Salvo G, Scalco G, Bozza F, Barutta L, Del Bianco P . A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg. 2008; 247(2):207-13. DOI: 10.1097/SLA.0b013e31812e6a73. View